Molecular Docking and 3-D QSAR Studies of Substituted 2,2-Bisaryl-Bicycloheptanes as Human 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors

QR Code

Molecular Docking and 3-D QSAR Studies of Substituted 2,2-Bisaryl-Bicycloheptanes as Human 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors

Leukotrienes have been shown to be involved in a variety of diseases such as cardiovascular diseases, cancer, asthma, ulcerative colitis, and rhinitis. 5-Lipoxygenase-Activating Protein (FLAP) was found to be a key enzyme of leukotriene synthesis. Comparative Molecular Field Analysis (CoMFA) and mol...

Full description

Bibliographic Details
Main Authors:	Ma, X., Zhou, L., Zuo, Zhili, Liu, J., Yang, M., Wang, R.
Format:	Journal Article
Published:	Wiley 2008
Online Access:	http://hdl.handle.net/20.500.11937/10087

Similar Items

Identification of novel 5-lipoxygenase-activating protein (FLAP) inhibitors by an integrated method of pharmacophore virtual screening, docking, QSAR and ADMET analyses
by: Rullah, Kamal, et al.
Published: (2023)

3D-QSAR studies of checkpoint kinase 1 inhibitors based on molecular docking and CoMFA
by: Wang, R., et al.
Published: (2010)

Docking study and three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses of transforming growth factor-ß type I receptor kinase inhibitors
by: tang, M., et al.
Published: (2009)

Synthesis and docking studies of 2,4,6-trihydroxy-3-geranylacetophenone analogs as potential lipoxygenase inhibitor
by: Chean, Hui Ng, et al.
Published: (2014)

Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking
by: Yadav, D., et al.
Published: (2017)

Group-based quantitative structure-activity relationship (G-QSAR) analysis and molecular docking of B-cell lymphoma two (BCL-2) inhibitors
by: Abdul Samat, Nadia Hanis, et al.
Published: (2013)

QSAR modeling for anti-human African trypanosomiasis activity of substituted 2-phenylimidazopyridines
by: Masand, Vijay Hariram, et al.
Published: (2017)

Molecular docking and structure-activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors
by: Xu, W., et al.
Published: (2010)

Application of group-based QSAR and molecular docking in the design of insulin-like growth factor antagonists
by: Abdullahi, Abubakar Danjuma, et al.
Published: (2015)

Characterisation of recombinant Hevea brasiliensis allene oxide synthase: Effects of cycloxygenase inhibitors, lipoxygenase inhibitors and salicyclate on enzyme activity
by: Norton, Gareth, et al.
Published: (2007)

Coordination chemistry of 2,2’-bipyridyl- and 2,2’:6’,2”-terpyridyl-substituted BEDT-TTFs: formation of a supramolecular capsule motif by the iron(II) tris complex of 2,2’-bipyridine-4-thiomethyl-BEDT-TTF
by: Wang, Qiang, et al.
Published: (2016)

Molecular docking unveils prospective inhibitors for the SARS-COV-2 main protease
by: Ahmad, Fawad, et al.
Published: (2021)

Synthesis, biological evaluation and QSAR studies of diarylpentanoid analogues as potential nitric oxide inhibitors
by: Mohd Faudzi, S. M., et al.
Published: (2015)

Molecular docking studies of selected medicinal drugs as dengue virus-2 protease inhibitors
by: Rufaidah Othman,, et al.
Published: (2017)

Identification of β-cycloidal-derived mono-carbonyl curcumin analogs as potential interleukin-6 inhibitor to treat wound healing through QSAR, molecular docking, MD simulation, MM-GBSA calculation
by: Forid, Md Shaekh, et al.
Published: (2024)

Identification of Inhibitor Binding Site in Human Sirtuin 2 Using Molecular Docking and Dynamics Simulations
by: Sakkiah, Sugunadevi, et al.
Published: (2013)

Acid inactivation of soybean lipoxygenase with retention of protein solubility
by: Cheman, Y.B., et al.
Published: (1989)

Effect of pH on the kinetics of soybean lipoxygenase‐1
by: Asbi, B. Ali, et al.
Published: (1989)

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors.
by: John, S., et al.
Published: (2011)

Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles
by: Yu, Chai Xin, et al.
Published: (2023)

Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles
by: Yu, Chai Xin, et al.
Published: (2023)

2-acetylthiophene thiosemicarbazone as mushroom tyrosinase inhibitor: insights from kinetic, RDG, molecular docking, and DFT studies
by: Ahmad, Mohammad Norazmi, et al.
Published: (2019)

Design and synthesis of a novel mPGES-1 lead inhibitor guided by 3D-QSAR CoMFA
by: Rullah, Kamal, et al.
Published: (2019)

A lazy learning-based QSAR classification study for screening potential histone deacetylase 8 (HDAC8) inhibitors
by: Cao, G., et al.
Published: (2015)

Design and synthesis of a novel mPGES-1 lead inhibitor guided by 3D-QSAR CoMFA
by: Mohd F. F., Mohd Aluwi, et al.
Published: (2019)

Predicting repurposed drugs targeting the NS3 protease of dengue virus using machine learning-based QSAR, molecular docking, and molecular dynamics simulations
by: Chongjun, Y., et al.
Published: (2024)

Antioxidant and Lipoxygenase Inhibiting New Iridoid Glucosides from Caryopteris Odorata
by: Akhtar, Muhammad Nadeem, et al.
Published: (2013)

Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening
by: Xu, W., et al.
Published: (2010)

Substituted 3-styryl-2-pyrazoline derivatives as an antimalaria : synthesis, in vitro assay, molecular docking, druglikeness analysis, and ADMET prediction
by: Linda Ekawati,, et al.
Published: (2022)

2,2-Dibenzylhydrazin-1-ium chloride
by: Tayamon, Shahedeh, et al.
Published: (2013)

Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: design, synthesis, QSAR analysis and anticancer activity.
by: Alafeefy, Ahmed M., et al.
Published: (2015)

3D QSAR pharmacophore modeling, in silico screening, and density functional theory (DFT) approaches for identification of human chymase inhibitors
by: Arooj, Mahreen, et al.
Published: (2011)

Synthesis and molecular docking of carvone derivatives as a potential neuraminidase inhibitors
by: Jusoh, Noorakmar, et al.
Published: (2016)

Molecular docking analysis of curcumin analogues as human neutrophil elastase inhibitors
by: Narayanaswamy, Radhakrishnan, et al.
Published: (2014)

α-glucosidase and 15-lipoxygenase inhibitory activities of phytochemicals from calophyllum symingtonianum
by: Aminudin, Nurul Iman, et al.
Published: (2015)

Synthesis And Molecular Docking Studies Of New Phenylisoxazole Quinoxaline-2-Amine Hybrids As Potential Α Amylase And Α-Glucosidase Inhibitors
by: Radzuan, Siti Nurshahira Mohd
Published: (2024)

Using 3D-QSAR to predict the separation efficiencies of flotation collectors: Implications for rational design of non-polar side chains
by: Yang, X., et al.
Published: (2018)

(1E)-1-(2-pyrazinyl)ethanone thiosemicarbazone (PT) as a tyrosinase inhibitor with anti-browning activity: Spectroscopy, DFT and molecular docking studies
by: Syamimi Sulfiza, Shamsuri, et al.
Published: (2023)

Unlocking therapeutic potential: identifying small molecule inhibitors for SARSCOV-2 variants’ main protease (MPRO) through molecular docking analysis
by: Chong, Yie Woon, et al.
Published: (2024)

Synthesis of thymidine phosphorylase inhibitor based on quinoxaline derivatives and their molecular docking study
by: Noor Barak, Almandil, et al.
Published: (2019)

Cannot write session to /tmp/vufind_sessions/sess_njhb053jdlvuvtsenqec411mja